Daan Gene Co., Ltd.

¥5.27As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002030Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (6.90%)
Div yield —
ROE (10.25%)
Biotechnology
Beta (5Y) 0.52
PE TTM —
TSR TTM (19.17%)
Mkt cap ¥7.396B
ROIC (4.96%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.06
(3.96%)
(44.24%)
Hold 4|0|4|6|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.06
0.07
0.08
(4.82%)
(5.03%)
10.76%
28.00%
Revenue¥M
474.5
484.2
494.9
500.1
10.87%
11.43%
11.65%
8.18%
Peers (US$1.109B)
Cap (US$)
PE
1.109B
18.76x
1.124B
34.63x
Capital
TTM
5Y
10Y
Leveragex
1.419
0.036
0.034
EBIT/Intx
1.410
0.095
0.123
Own earn%
65.86
34.59
45.70
Sh yield%
27.39
18.30
19.26
Owners
Insiders/Inst%
7.59
21.84
Short interest%
5.61
SBC / revenue%
5.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
22–27
$1 testx
0.5
Incr. ROIC%
18